Amorphical

Amorphous Calcium Carbonate Products

Health Tech & Life Sciences
Active
Mature Ness Ziona, Israel Founded 2004
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
$28.3M
Last: 2021-01
Stage
Mature
Founded
2004
Headcount
50
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

Amorphical is a pioneering biotechnology company that develops and manufactures unique natural-based medicines and dietary supplements with high bio-availability, aiming at the improvement of calcium absorption and management, in tandem with balancing the body's acidity level (pH) derived by various biomedical conditions. These features are critical for maintaining health, repairing bone deficiencies, treating severe diseases, and aiding the development and strengthening of the body.

Amorphical’s leading scientists succeeded in stabilizing and preserving a rare natural form of calcium used by blue crayfish to develop a unique nanometric substance called amorphous calcium carbonate, which helps improve people's health and quality of life.

Funding history · 6 rounds · $28.3M total

2021-01
$6.0M
2020-01
$1.0M
ICU group
2016-05
$8.8M
2014-03
$8.0M
2013-05
Grant $2.7M
2010-03

Q&A

What is Amorphical's primary business?
Amorphical is a biotechnology company that develops and manufactures natural-based medicines and dietary supplements using amorphous calcium carbonate to improve calcium absorption and manage body acidity.
When was Amorphical founded?
Amorphical was founded in July 2004.
Where is Amorphical headquartered?
Amorphical is headquartered in Ness Ziona, Center District, Israel.
How many employees does Amorphical have?
Amorphical has 11-50 employees.
What is Amorphical's total funding to date?
Amorphical has raised a total of $28,300,000 USD.
When was Amorphical's most recent funding round and how much was raised?
Amorphical's most recent funding round was in January 2021, raising $6,000,000 USD.
Which investor participated in Amorphical's January 2020 funding round?
ICU group participated in Amorphical's January 2020 funding round.
Who is the Founder and Chairman of Amorphical?
Yossi Ben is the Founder and Chairman of Amorphical.
What is Amorphical's current product stage?
Amorphical's product is currently released.

Team · 1

Yossi Ben
Founder · Founder & Chairman
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & Substances
Target customers
Industrial ManufacturingDiscrete IndustriesAerospaceHealthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcarePatients
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

pharmaceuticalssupplementsbiotechnologynutritioninvestorsprivate-investorspharma-companiesnovel-ingredientshospitalswellnessosteoporosiscancerspace-tech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)